查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566956

乙醇脱氢酶市场：按类型、按应用划分：2024-2033 年全球机会分析与产业预测

Alcohol Dehydrogenase Market By Type (Medium-chain Enzymes, Short-chain Enzymes) , By Application (Alcohol Concentration Detection, Disease Diagnosis, Catalyst) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年乙醇脱氢酶市值为6亿美元，预计2024年至2033年复合年增长率为6.5%，到2033年将达11亿美元。

乙醇脱氢酶是一种含锌酶，主要负责将酒精氧化成醛和酮。这种酵素主要在人类肝臟和胃中合成，是对抗有毒分子酒精的主要防御手段。酒精脱氢酶在使这种潜在有害分子对食品无害方面发挥重要作用，从而防止毒性水平的积累并排放体内的酒精。

全球酒精脱氢酶市场的成长主要是由全球酒精消费量的增加以及酒精相关疾病盛行率的惊人增加所推动的。这是因为乙醇脱氢酶可以减轻酒精的中毒作用并促进其从体内排出。根据世界卫生组织（WHO）的说法，酒精是一种已知的致癌物质，并且会增加癌症的风险。 2019 年，约有 401,000 人因饮酒而死亡。此外，人们对酒精相关健康问题的认识不断提高，以及对有效诊断工具和治疗的需求正在推动对乙醇脱氢酶的需求。此外，绿色化学中越来越多地采用醇脱氢酶对市场成长做出了重大贡献。然而，乙醇脱氢酶的高製造成本限制了市场的成长。此外，製造过程的复杂性、对先进技术和熟练技术人员的需求导致了额外的成本，这进一步限制了市场的成长。相反，诊断技术的进步，例如更准确、更有效地测量乙醇脱氢酶活性的检测方法，预计将为预测期内的市场成长提供有利的机会。此外，生物技术和酵素工程的创新正在促进新的乙醇脱氢酶产品和应用的开拓，例如重组乙醇脱氢酶和改进的诊断分析，预计将为市场扩张开闢新的途径。

乙醇脱氢酶产业按类型、应用和区域细分。依类型，市场分为中链酶和短链酶。依用途分为酒精浓度检测、疾病诊断、催化剂等。从区域来看，分析包括北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按类型划分，中链细分市场将在 2023 年占据市场主导地位。

从应用来看，2023年酒精浓度检测领域将占据主要市场份额。

按地区划分，北美地区 2023 年成长最快。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 监管指引
  • 根据客户兴趣新增其他公司简介
  • 历史市场资料
  • 赎回场景

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章醇脱氢酶市场：依类型

  • 市场概况
  • 中链酶
  • 短链酶

第五章醇脱氢酶市场：依应用分类

  • 市场概况
  • 酒精浓度检测
  • 疾病诊断
  • 催化剂

第六章酒精降解酵素市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国乙醇脱氢酶市场
    • 加拿大乙醇脱氢酶市场
    • 墨西哥乙醇脱氢酶市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国乙醇脱氢酶市场
    • 德国乙醇脱氢酶市场
    • 义大利乙醇脱氢酶市场
    • 西班牙乙醇脱氢酶市场
    • 英国乙醇脱氢酶市场
    • 其他欧洲醇脱氢酶市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国乙醇脱氢酶市场
    • 日本乙醇脱氢酶市场
    • 印度乙醇脱氢酶市场
    • 韩国乙醇脱氢酶市场
    • 澳洲乙醇脱氢酶市场
    • 其他亚太醇脱氢酶市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西乙醇脱氢酶市场
    • 南非乙醇脱氢酶市场
    • 沙乌地阿拉伯乙醇脱氢酶市场
    • 其他拉丁美洲/中东/非洲乙醇脱氢酶市场

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第八章 公司简介

  • Sigma-Aldrich
  • Thermo Fisher Scientific
  • BioVision Inc.
  • Creative Enzymes Technologies, LLC
  • MP Biomedicals
  • Randox Laboratories Limited
  • Sekisui Diagnostics
  • Prospec-Tany Technogene Ltd.
  • Roche Diagnostics
  • Worthington Biochemical Corp.
简介目录
Product Code: A324360

The alcohol dehydrogenase market was valued at $0.6 billion in 2023, and is projected to reach $1.1 billion by 2033, growing at a CAGR of 6.5% from 2024 to 2033.

Alcohol dehydrogenase is class of zinc-containing enzyme that is majorly responsible for the oxidation of alcohols to aldehydes or ketones. This enzyme is predominantly synthesized liver and stomach of humans that acts as a primary defense against a toxic molecule, alcohol. Alcohol dehydrogenase detoxifies this potentially harmful molecule into a mere foodstuff, thereby playing a critical role in preventing the accumulation of toxic levels and eliminating alcohol from the body.

The growth of the global alcohol dehydrogenase market is majorly driven by rise in global alcohol consumption and alarming increase in prevalence of alcohol-related diseases. This is attributed to the fact that alcohol dehydrogenase mitigates the intoxicating effects of alcohol and facilitates its excretion from the body. According to the World Health Organization, alcohol is an established carcinogen and is known to increase the risk of cancer. Approximately 401,000 cancer deaths were registered in 2019 due to alcohol consumption. In addition, rise in awareness about alcohol-related health issues and the need for effective diagnostic tools and treatments boosts the demand for alcohol dehydrogenase. Moreover, increase in adoption of alcohol dehydrogenase in green chemistry notably contributes toward the growth of the market. However, high production cost of alcohol dehydrogenase restrains the growth of the market. Furthermore, the complexity associated with the production process and the need for advanced technology and skilled technicians incur additional costs, which further restrict the market growth. On the contrary, advances in diagnostic technologies, such as more accurate and efficient assays for measuring alcohol dehydrogenase activity, are expected to offer remunerative opportunities for the market growth during the forecast period. Furthermore, technological innovations in biotechnology and enzyme engineering contribute to the development of new alcohol dehydrogenase products and applications, including recombinant alcohol dehydrogenase enzymes and improved diagnostic assays, which are anticipated to open new avenues for the expansion of the market.

The alcohol dehydrogenase industry is segmented into type, application, and region. On the basis of type, the market is bifurcated into medium-chain enzymes and short-chain enzymes. On the basis of application, the market is segregated into alcohol concentration detection, disease diagnosis, and catalyst. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the medium-chain segment dominated the market in 2023.

On the basis of application, the alcohol concentration detection segment held a major share of the market in 2023.

Region wise, North America exhibited the highest growth in 2023.

Competition Analysis

Competitive analysis and profiles of the major players in the global alcohol dehydrogenase market include Sigma-Aldrich, Thermo Fisher Scientific, BioVision Inc., Creative Enzymes Technologies, LLC, MP Biomedicals, Randox Laboratories Limited, Sekisui Diagnostics, Prospec-Tany Technogene Ltd., Roche Diagnostics, and Worthington Biochemical Corporation These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Type

  • Medium-chain Enzymes
  • Short-chain Enzymes

By Application

  • Alcohol Concentration Detection
  • Disease Diagnosis
  • Catalyst

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Sigma-Aldrich
    • Thermo Fisher Scientific Inc.
    • BioVision Inc.
    • Creative Enzymes Technologies, LLC
    • MP Biomedicals
    • Randox Laboratories Limited
    • Sekisui Diagnostics
    • Prospec-Tany Technogene Ltd.
    • Roche Diagnostics
    • Worthington Biochemical Corp.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ALCOHOL DEHYDROGENASE MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Medium-chain Enzymes
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Short-chain Enzymes
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Alcohol Concentration Detection
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Disease Diagnosis
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Catalyst
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ALCOHOL DEHYDROGENASE MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By Application
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Alcohol Dehydrogenase Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By Application
    • 6.2.6. Canada Alcohol Dehydrogenase Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By Application
    • 6.2.7. Mexico Alcohol Dehydrogenase Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By Application
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By Application
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. France Alcohol Dehydrogenase Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By Application
    • 6.3.6. Germany Alcohol Dehydrogenase Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By Application
    • 6.3.7. Italy Alcohol Dehydrogenase Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By Application
    • 6.3.8. Spain Alcohol Dehydrogenase Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By Application
    • 6.3.9. UK Alcohol Dehydrogenase Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By Application
    • 6.3.10. Rest of Europe Alcohol Dehydrogenase Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By Application
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. China Alcohol Dehydrogenase Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By Application
    • 6.4.6. Japan Alcohol Dehydrogenase Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By Application
    • 6.4.7. India Alcohol Dehydrogenase Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By Application
    • 6.4.8. South Korea Alcohol Dehydrogenase Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By Application
    • 6.4.9. Australia Alcohol Dehydrogenase Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By Application
    • 6.4.10. Rest of Asia-Pacific Alcohol Dehydrogenase Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By Application
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By Application
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Alcohol Dehydrogenase Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By Application
    • 6.5.6. South Africa Alcohol Dehydrogenase Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By Application
    • 6.5.7. Saudi Arabia Alcohol Dehydrogenase Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By Application
    • 6.5.8. Rest of LAMEA Alcohol Dehydrogenase Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Sigma-Aldrich
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Thermo Fisher Scientific
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. BioVision Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Creative Enzymes Technologies, LLC
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. MP Biomedicals
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Randox Laboratories Limited
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Sekisui Diagnostics
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Prospec-Tany Technogene Ltd.
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Roche Diagnostics
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Worthington Biochemical Corp.
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments